RP
CHNG

Reinhart Partners’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Reinhart Partners’s Portfolio CHNG Stock Details CHNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-389,769
Closed -$10.8M – 86
2022
Q3 		$10.8M Sell
389,769
-985,663
-72% -$24.4M 0.67% 67
2022
Q2 		$31.7M Sell
1,375,432
-84,073
-6% -$1.96M 1.74% 15
2022
Q1 		$31.8M Sell
1,459,505
-108,050
-7% -$2.24M 1.54% 20
2021
Q4 		$33.5M Buy
1,567,555
+42,653
+3% +$894K 1.61% 18
2021
Q3 		$31.9M Buy
1,524,902
+279,434
+22% +$6.1M 1.62% 19
2021
Q2 		$28.7M Sell
1,245,468
-259,871
-17% -$5.98M 1.43% 23
2021
Q1 		$33.3M Buy
1,505,339
+91,246
+6% +$2.11M 1.73% 19
2020
Q4 		$26.4M Sell
1,414,093
-106,273
-7% -$1.75M 1.6% 19
2020
Q3 		$22.1M Buy
1,520,366
+125,363
+9% +$1.59M 1.66% 14
2020
Q2 		$15.6M Buy
1,395,003
+599,684
+75% +$6.74M 1.19% 41
2020
Q1 		$7.95M Buy
+795,319
New +$11.1M 0.77% 64

Other funds holding CHNG

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Reinhart Partners's CHNG Position: Q4 2022 in Review

Reinhart Partners sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 389,769 shares — an estimated $10.8M sold.

Reinhart Partners first reported a position in CHNG in Q1 2020 and held it in 11 quarters. The position peaked at $33.5M in Q4 2021. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Reinhart Partners reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Reinhart Partners sold 389,769 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $10.8M.
  • Reinhart Partners first reported a position in Change Healthcare Inc. Common Stock in Q1 2020 and held it in 11 quarters.
  • Reinhart Partners's Change Healthcare Inc. Common Stock position peaked at $33.5M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Reinhart Partners's 13F filing for Q4 2022, filed 18 Jan 2023.